ROCK inhibition has also demonstrated vascular benefits in diabetic macular edema (DME), including reduction in central foveal thickness independent of IOP effects, likely through mechanisms such as stabilization of endothelial tight junctions and VEGF suppression [45]. The gene discussed is VEGFA; the disease is diabetic macular edema.